Coronary/Structural Heart

BioCardia Completes Roll-In Cohort In Pivotal Phase III CardiAMP Heart Failure Trial

SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced completion of treatment for the 10-patient roll-in cohort for the pivotal Phase III CardiAMP Heart Failure Trial. A pre-specified review of the 30-day outcomes in this cohort by the Data […]

ABBOTT INITIATES CLINICAL TRIAL OF THREE-MONTH DUAL ANTIPLATELET THERAPY FOLLOWING IMPLANTATION WITH XIENCE CORONARY STENT

PRESS RELEASE ABBOTT PARK, Ill., July 25, 2017 — Abbott today announced that the first patient has been enrolled in a clinical study evaluating the short-term use of common blood thinning medicines, called dual antiplatelet therapy (DAPT), after receiving a XIENCE everolimus-eluting coronary stent. The study, called XIENCE Short DAPT, […]

Roxwood Medical Announces Agreement With Abbott (ABT) For Distribution Of Products In U.S.

REDWOOD CITY, Calif., July 25, 2017 /PRNewswire/ — Roxwood Medical Inc., a leading provider of advanced cardiovascular specialty catheters, today announced it has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the United States. “This partnership with Abbott’s vascular business is a major milestone for Roxwood that allows far […]

AAP counsels pediatricians to focus on clusters of cardiometabolic risk factors to help obese kids

WASHINGTON, July 24, 2017 /PRNewswire-USNewswire/ — Because obesity affects one in six U.S. children and adolescents, there is a pressing need to identify the subset of overweight or obese kids at the highest risk of developing cardiovascular and metabolic complications and to direct interventions to them. Since frameworks used to identify adults […]

4C Medical rakes in $9M

TMVR dev 4C Medical raises $9m JULY 20, 2017 BY FINK DENSFORD – MassDevice Structural heart disease device maker 4C Medical said today it completed a private placement of unsecured convertible promissory notes, raising approximately $9 million to help support development of its transcatheter tech designed to treat mitral regurgitation. The financing was led by […]

ClearFlow Expands Distribution Of Pleuraflow System For Pediatric Cardiothoracic Surgery

ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has announced a full market release for the 20Fr SEDL version of the PleuraFlow® Active Clearance Technology® System for the treatment of pediatric cardiothoracic surgery patients. The SEDL refers to the “shorter effective drainage length,” which facilitates placement of the […]

CV Sciences, Inc. Cites Recent Clinical Study On Pharmaceutical-Grade CBD Shown To Lower Blood Pressure

Company Gaining Traction with Drug Candidate CVSI-007 to Become the Only FDA Approved Treatment for Smokeless Tobacco Addiction LAS VEGAS, NV–(Marketwired – July 20, 2017) – CV Sciences, Inc. (OTCQB: CVSI) (the “Company,” “CV Sciences,” “our” or “we”), highlights a recent clinical study using pharmaceutical grade cannabidiol (CBD) which suggests that CBD […]

Should We Be Warning Teenagers Against Using Energy Drinks?

By Ken Dropkiewski (ken@prime-core.com) In a recent randomized study, researchers determined patients with familial long QT syndrome are susceptible to an increase in symptoms ranging from rapid and irregular heart rate to sudden death just from drinking heavily caffeinated energy drinks. As reported in the International Journal of Cardiology, researchers […]

Fiber Endoscope Imaging Developer VerAvanti Raises $5M

Cardiac imaging dev VerAvanti raises $5m JULY 18, 2017 BY FINK DENSFORD, MassDevice Previously-stealthy cardiac imaging developer VerAvanti said today it raised $5 million in a recent round of financing to support its Scanning Fiber Endoscope device development. The Redmond, Wash.-based company’s SFE device uses technology licensed from the University of Washington and consists […]